MedAdvisor has never really had ‘cash’, at least not at the levels seen now.
What are they going to do with $33M?
They still need to demonstrate $40M+ revenue in H2 to show what’s earned in December isn’t eroded. Costs of doing business and inflation is on the rise. I suspect they might plan a price rise for AU/NZ pharmacies using PlusOne.
- Pay out/down debt ($13M)
- New product development
- Grow sales teams to target more revenue
- Break through in new markets (UK)
- New acquisition
- Rainy day war chest
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.35M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12500 | 8.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 10000 | 1 |
View Market Depth
| Last trade - 07.00am 17/06/2025 (20 minute delay) ? |
| MDR (ASX) Chart |
Day chart unavailable